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Replication of bovine papillomavirus requires two viral proteins, E1 and E2-TA. Previously we demonstrated
that sequences within an imperfect 18-bp inverted repeat (IR) element were sufficient to confer specific binding
of the E1 protein to the origin region (S. E. Holt, G. Schuller, and V. G. Wilson, J. Virol. 68:1094–1102, 1994).
To identify critical nucleotides for E1 binding and origin function, a series of individual point mutations was
constructed at each nucleotide position in the 18-bp IR. Binding of E1 to these point mutations established that
both the position of the mutation and the specific nucleotide change were important for the E1-DNA interac-
tion. Equivalent mutations from each half of the IR exhibited similar binding, suggesting that the halves were
functionally symmetric for E1 interactions. Each of these mutations was evaluated also for origin function in
vivo by a transient-replication assay. No single point mutation eliminated replication capacity completely,
though many mutants were severely impaired, demonstrating an important functional contribution for the E1
binding site. Furthermore, E1 binding was not sufficient for replication, as several origin mutants bound E1
well in vitro but replicated poorly in vivo. This suggests that certain nucleotides within the 18-bp IR may be
involved in postbinding events necessary for replication initiation. The results with the point mutations suggest
that E1-E1 interactions are important for stable complex formation and also indicate that there is some
flexibility with regard to formation of a functional E1 replication complex at the origin.
Papillomaviruses have small, double-stranded, circular DNA
genomes that replicate episomally in infected cells (7, 9, 15, 16,
38, 54). Productive infection is generally restricted to the nat-
ural host, and only a portion of the viral life cycle is recapitu-
lated in cultured cells. Bovine papillomavirus type 1 (BPV-1)
has been the prototype for studies of papillomavirus replica-
tion (30, 31, 46, 47, 51, 53). The introduction of BPV-1 into
mouse cell lines results in a transient amplification of the viral
genome followed by persistence at a relatively constant copy
number (3, 4, 23, 24, 34). In the culture system, a single origin
of replication, which encompasses the unique HpaI site on the
viral genome (47), has been defined. This same region also
functions as an origin of replication in vitro with mouse cell
extracts (14, 30, 51, 53). In vivo only two viral proteins, full-
length E1 and E2-TA, are required for replication, with the
remainder of the replication machinery supplied by the host
cell (46). Replication in vitro does not absolutely require either
E2-TA or an E2 binding site, though E2-TA greatly enhances
replication, especially at low concentrations of E1 (6, 14, 19,
30, 32, 51).
E1 is a multifunctional, nuclear (17, 18) phosphoprotein (5,
37, 42) with origin binding specificity (10, 11, 26, 27, 29, 39–41,
44, 46, 48, 51, 53), helicase activity (40, 52), ATPase activity
(28), and the ability to form complexes with the E2-TA protein
(5, 25, 29, 44) and the large subunit of DNA polymerase a (32).
In the presence of ATP, E1 bound to the origin causes struc-
tural distortions, primarily in the AT-rich region (10). The
addition of E2-TA enhances E1 binding to the origin (26, 27,
29, 39, 41, 51, 53), with little or no change in the overall pattern
of E1-induced structural changes (10). It has been proposed
that E2-TA mediates the initial assembly of E1 at the origin
but that the functional replication complex consists of multim-
eric E1 without bound E2-TA (27). In addition to having a role
in mediating E1 assembly at the origin, E2-TA has been shown
to bind replication protein A (19) and to overcome nucleo-
some repression of BPV-1 replication in vitro (20). All of these
functions of E2-TA may contribute to its absolute requirement
for in vivo replication of BPV-1.
Initial DNA binding studies indicated that the E1 protein, in
the absence of E2-TA, could bind to two regions on the viral
genome (29, 48, 53). Strong binding was observed in the vicin-
ity of the HpaI site, along with weak binding to an additional
region approximately 250 bp upstream of the HpaI site (48,
53). Subsequent footprinting studies of the HpaI region re-
vealed an extended region of protection on both DNA strands
(10, 11, 47, 51). Within this extended region was a major
protected region between nucleotides 7932 and 15 that encom-
passed the HpaI site (11, 47). Examination of the sequences
within the major protected region revealed two alternative,
overlapping, imperfect inverted repeats (IR) of 28 and 18 bp,
respectively (8, 11, 47, 51, 53). Using double-stranded oligo-
nucleotides corresponding to each IR, we recently demon-
strated that sequences within the 18-bp IR were necessary and
sufficient to confer E1-specific DNA binding (11). However,
formation of a stable E1-DNA complex required the presence
of additional sequences beyond the boundaries of the 18-bp
IR. Since these flanking sequences were not derived from
BPV-1, their functions appear to be sequence nonspecific.
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These data suggest that E1 makes extended contacts with the
DNA backbone and that the flanking sequences contribute to
overall E1-DNA complex stability.
The previous studies indicated that E1 binding required
sequences within the 18-bp IR element, but little is known
about the substructure of this region or about specific nucle-
otides critical for E1 binding and replication function. While
several mutations within this region have already been evalu-
ated, these were primarily deletions, insertions, and multiple
point mutations (11, 26, 39, 41, 44, 47). Interpretation of these
mutations, especially the deletion and insertion mutations, can
be difficult, since they affect not only the sequence but also the
spacing and relative helical position between potential ele-
ments involved in E1 binding and origin function. To evaluate
the 18-bp region more systematically, we constructed a large
set of individual point mutations throughout this region. Each
mutant DNA was tested for in vitro E1 binding and for in vivo
replication. Comparison of the binding and replication prop-
erties of these mutants confirmed the importance of sequences
within the 18-bp element for E1 binding and origin function,
identified specific nucleotides that were critical for replication,
and suggested that certain nucleotides contributed to postbind-
ing replication functions.
MATERIALS AND METHODS
Plasmids and phage. Plasmid pBOR was previously designated ORI-105 (11)
and contains the 105-bp BPV-1 fragment from nucleotides 7892 to 52. M13BOR
contains the same BPV-1 fragment inserted into M13mp18 (50). Plasmid
pBOR622 was constructed by ligating a 622-bp HindIII-SalI fragment, derived
from the pBR322 tetracycline gene region, into pBOR cut withHindIII plus SalI.
The resultant plasmid had the same replication properties as pBOR but was
easily distinguished from pBOR on agarose gels because of its larger size. The
pBOR622 plasmid was used as an internal standard in transient-replication
assays. Plasmids pCGEAG-E1 and pCG-E2 (generous gifts of A. Stenlund)
expressed full-length E1 and E2, respectively (46). Plasmid DNAs were purified
by cesium chloride gradients or with Qiagen columns (Qiagen, Inc.) and were
quantitated by spectrophotometry (optical density at 260 nm). Single-stranded
phage DNA was purified by standard procedures (36).
Cell culture. C127 and CHO cell lines were used for electroporation as pre-
viously described (8, 46, 47). C127 cells were maintained in Dulbecco minimal
essential medium and 10% fetal bovine serum and were used at passages 11 to
15. CHO cells were maintained in Ham’s F12 medium with 10% fetal bovine
serum.
Mutagenesis of the 18-bp IR region. Point mutations were created by in vitro
mutagenesis with single-stranded M13BOR DNA and a degenerate oligonucle-
otide as previously described (50). Phage plaques formed from the mutagenized
M13BOR DNA were screened by PCR and single-stranded conformation poly-
morphism to identify potential mutations and then were confirmed by DNA
sequencing with the double-stranded DNA Cycle Sequencing kit (GIBCO BRL).
This procedure yielded numerous single point mutations as well as several
multiple point mutations and two small deletion mutations. The identified mu-
tations were distributed throughout most of the nucleotide positions of the 18-bp
IR region except a few positions within the central HpaI recognition sequence.
Mutations at these positions were constructed with specific oligonucleotides
containing a single mutated base. All single point mutations were designated
according to the nucleotide position of their mutation and the nucleotide change.
Preparation of DNA fragments for binding assays. Radiolabeled DNA frag-
ments were prepared by incorporation of [a-32P]TTP during PCR amplification
(33, 50) of M13BOR and each of the mutant derivatives with primer 1 (59-
TGTGGAATTGTGAGCGGATAAC-39) and primer 2 (59-TTCCCAGTCAC
GACGTTGTAAA-39). These PCR primers were from the flanking M13 se-
quences and resulted in amplification products of 256 bp. All the DNA fragments
to be generated for a particular DNA binding experiment (see below) were
prepared with a common reaction mixture stock and were amplified in a single
PCR run so that specific activities would be equivalent; this was confirmed by
direct measurement of specific activities. For the ratio binding assay (see below)
a radiolabeled 205-bp origin-containing fragment was prepared from M13BOR
by PCR incorporation with primer 1 and primer 3 (59-GACCATGATTAC
GAATTCGAGC-39). In addition, a 151-bp fragment lacking the origin was
prepared by PCR amplification of pUC18 with primers 1 and 2.
DNA binding assays. Bacterial extracts containing or lacking the RecA-E1
protein were prepared as previously described (48). Binding of RecA-E1 to
wild-type and mutant DNA fragments was evaluated by an immunoprecipitation
assay as previously described for cloned oligonucleotides (11). Briefly, 10 ml of
bacterial extract was immunoprecipitated with anti-E1 antibody 5996 or preim-
mune serum, and the pellet was washed three times with 1 ml of 10 mM TNE (10
mM Tris-HCl [pH 7.0], 10 mM NaCl, 0.01 mM EDTA) supplemented with 200
mM NaCl, 0.25% Nonidet P-40, and 5 mg of sheared salmon sperm DNA per ml
and was washed one time with 1 ml of 10 mM TNE as described previously (49).
These samples were then incubated at 258C for 30 min with excess radiolabeled
PCR-amplified fragments in 150 mM TNE (10 mM Tris-HCl [pH 7.0], 150 mM
NaCl, 0.01 mM EDTA). In the direct assay, each sample contained a single
species of radiolabeled DNA, either the wild type or one of the mutant frag-
ments, while in the ratio assay, an equal amount of the 205-bp wild-type origin
PCR fragment or of the 151-bp nonorigin PCR fragment was included with each
256-bp DNA fragment to serve as an internal standard and competitor. After
incubation, the samples were washed three times with 1 ml of 10 mM TNE
supplemented with 200 mM NaCl, 0.25% Nonidet P-40, and 5 mg of sheared
salmon sperm DNA. A final wash was done with 1 ml of 10 mM TNE. Washed
pellets were incubated with 15 to 60 mg of proteinase K for 30 min at 558C, and
then the labeled DNA was extracted with TBE sample buffer (89 mM Tris, 89
mM boric acid, 2.5 mM EDTA, 10% glycerol, 2.7% xylene cyanol, 2.4% bromo-
phenol blue, 1.5% sodium dodecyl sulfate [SDS]). The extracted DNA was
electrophoresed on 8 or 10% Tris-borate polyacrylamide gels. Gels were dried
and exposed to X-ray film for autoradiography with an intensifier screen. The
relative amount of each bound DNA fragment was quantitated by densitometric
analysis of the autoradiographs with the IS-1000 Digital Imaging System (Inno-
tech Scientific Corp.). All autoradiographs used for the quantitative analysis had
exposures below the saturation level of the film. For each mutation analyzed in
the ratio assay, the ratio of bound 256-bp mutant fragment to 205-bp wild-type
fragment was normalized to the ratio of a control sample containing both 256-bp
and 205-bp wild-type fragments.
Transient DNA replication assays. In the ratio assay (see below), C127 cells (2
3 106 cells per electroporation) were electroporated with 5 mg of pBOR plasmid
(wild type or mutant), 1 mg of pBOR622 plasmid, 3 to 5 mg of pCGEAG-E1, and
3 to 5 mg of pCG-E2. For the direct assay, the pBOR622 DNA was not included.
At 8 to 12 h postelectroporation, the cells were washed with phosphate-buffered
saline, pH 7.5, and the medium was changed. Cells were maintained 3 to 5
additional days before harvesting.
The electroporation of CHO cells (5 3 106 cells per electroporation) was
performed as described previously (8), with the same quantities of plasmids as
was used for C127 cells. The medium was also changed as described above, but
cells were harvested only 2 to 4 days after the medium was changed. All cells
were incubated at 378C in 5% CO2 until harvested.
Cells were harvested by the Hirt method as previously described (31) with the
following modifications. Briefly, cells were lysed with 800 ml of lysis buffer (10
mM Tris-HCl [pH 7.6], 20 mM EDTA, 0.6% SDS) for 15 min at room temper-
ature. After lysis, 250 ml of 5 M NaCl was added, and the lysates were incubated
at 48C overnight. The samples were centrifuged at 12,0003 g for 30 min to pellet
cellular debris, and then the lysates were transferred to a sterile tube and
digested with 100 mg of proteinase K per ml for 6 to 12 h. The samples were then
extracted with an equal volume of phenol-chloroform, extracted once with chlo-
roform alone, and precipitated with 0.6 to 1 volume of isopropanol at 2208C for
1 to 4 h. The samples were centrifuged at 12,000 3 g for 30 min, and the nucleic
acid pellets were rinsed with 70% ethanol. Pellets were dried, resuspended in 20
ml of TE (10 mM Tris-HCl [pH 7.0], 0.01 mM EDTA) with 20 mg of RNase per
ml, and incubated for 20 min at 688C. The entire 20-ml sample was digested for
16 h at 378C with 10 to 100 U of DpnI to cleave unreplicated DNA and 10 U of
HindIII to linearize the plasmids. In parallel control samples consisting of
pUC18 DNA or pBOR electroporated without the E1 expression vector, this
digestion procedure was sufficient to eliminate all unreplicated input DNA.
Samples were electrophoresed on 1% agarose gels and transferred to nylon by
the downward Southern blot method (13). Membranes were baked at 808C for 30
to 60 min. pBOR DNA was radiolabeled with the Megaprime Random Priming
kit (Amersham) as recommended by the manufacturer, and the hybridization
(658C) and subsequent washes were done with the radiolabeled pBOR probe as
recommended in the Megaprime kit. Quantitation of hybridization to pBOR
(wild type and mutants) and pBOR622 DNA was done with the PhosphorIm-
aging System from Molecular Dynamics. For the direct assay, the amount of
replication of each mutant origin plasmid was compared directly with the amount
of replication of pBOR run in parallel. In the ratio assay, the amount of repli-
cated mutant plasmids was normalized by the recovery of the internal replication
standard (pBOR622) prior to comparison with wild-type pBOR replication. All
assays for quantitation were performed three to five times, and the results were
averaged.
RESULTS
Creation of BPV-1 origin mutations and experimental de-
sign for DNA binding assays. The origin of replication for
BPV-1 contains an AT-rich region, an E1 binding region, and
an adjacent E2-TA binding site (Fig. 1). The E1 binding region
was defined initially by DNase I footprinting and encompasses
a dyad symmetry region with alternative, overlapping IR ele-
ments of 18 and 28 bp (8, 11, 47, 51, 53). More recently we
showed that sequences within an 18-bp IR element are neces-
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sary and sufficient to confer specific binding by E1 protein (11).
Neither half of the IR element alone is sufficient for E1 binding
(11), but little else is known about the specific sequence re-
quirements.
To develop a more detailed understanding of E1-DNA in-
teractions in the 18-bp IR region, we constructed a large set of
single and multiple point mutations throughout this region at
each nucleotide position in the element. All of the individual
point mutations and two of the double mutations obtained are
shown in Fig. 2. For 7 of the 18 positions of the 18-bp element,
we isolated two different mutations, while we have isolated
only single mutations at the other 11 positions. There are also
two mutations, 7933C and 14C, from sequences flanking the
18-bp element. All of these mutations were in the background
of M13BOR, which contains a 105-bp fragment of wild-type
BPV-1 from nucleotides 7892 to 52. The fragment contains all
the cis components of the minimal functional origins in vivo
and in vitro (8, 14, 30, 47, 51, 53), as well as additional BPV-1
flanking sequences.
To assess binding of E1 to the various mutant DNAs, uni-
formly radiolabeled wild-type (256- or 205-bp) and mutant
(256-bp) DNA fragments were prepared to equal specific ac-
tivities by PCR with primer sets from the flanking M13 se-
quences as described in Materials and Methods. The binding
of E1 to each mutant DNA was evaluated by the previously
described immunoprecipitation assay (direct assay [11]) or a
modified competition form of the assay (ratio assay). For the
direct assay, binding reaction mixtures contained a single DNA
fragment derived from either the wild-type origin or mutated
origins. In the ratio assay, a 205-bp wild-type DNA fragment
was included in each reaction mixture along with the 256-bp
fragment being tested. The 205-bp wild-type fragment served
as both an internal standard to normalize variation in sample
recovery and also as a competitor which enhanced differences
between binding of E1 to wild-type and mutant DNAs. For
both the direct and ratio assays, the binding reactions were
performed in DNA excess as demonstrated by titration exper-
iments (data not shown). Where quantitations are given, each
value represents the average of three to six independent ex-
periments.
Binding of E1 to mutated 18-bp IR sequences. A represen-
tative ratio binding assay for the single point mutations is
shown in Fig. 3. To demonstrate the specificity of the ratio
assay, binding was done with a mixture of an origin-containing
fragment and a fragment lacking BPV sequences (lanes A to
D). Neither fragment was bound in the absence of E1 (lane B)
or when preimmune serum was used for the precipitation step
(lane C). In the presence of E1 and the anti-E1 serum, only the
origin-containing fragment was bound (lane D), indicating that
the E1-DNA interaction is highly specific for origin sequences
under these binding conditions.
When the ratio assay consisted of two fragments of different
overall length but containing identical wild-type BPV-1 origin
sequences (Fig. 3, lane WT), there was equivalent binding to
both fragments (the ratio of upper to lower bands was approx-
imately 1 after correction for differences in fragment sizes).
This is the predicted result for binding conditions under which
both DNA substrates are in excess and E1 interacts equally
FIG. 1. The bovine papillomavirus type 1 (BPV-1) genome. There are eight early open reading frames (E1 through E8) and two late open reading frames (L1 and
L2). Arrows indicate locations of known promoters with the nucleotide positions as indicated. The viral origin of replication (ORI) is located at the unique HpaI site
within the upstream regulatory region (URR) and is shown in detail in the expanded box. Replication of the virus requires two viral proteins: E1 and E2-TA. The E1
binding site, the E2 binding site, and the AT-rich region represent the minimal BPV-1 origin of replication. Brackets below the origin schematic denote the locations
of DNA fragments that function as origins of replication in vitro (19) and in vivo (45).
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well with each. In contrast, individual point mutations within
the 18-bp IR region varied greatly in the relative binding of E1
to the long mutant fragment compared with binding to the
short wild-type fragment. Some mutant fragments, such as
7942C, 10C, and 12C, were bound as well as the wild-type
fragment was, while others, such as 7943T and 8G, were se-
verely reduced in their binding by E1. The remainder of the
mutants displayed a range of E1 binding between these two
extremes. In no case, however, did a single point mutation
completely eliminate binding by the E1 protein.
Figure 4A shows a quantitative summary of the average
relative binding for the single point mutations as determined
by the ratio assay. A qualitatively identical pattern was ob-
tained with the direct assay (not shown). Fourteen of twenty-
five nucleotide changes within the 18-bp IR element decreased
E1 binding to less than 50% compared with that of the wild-
type origin sequence. These 14 mutations were located at 13 of
18 positions in the IR element, confirming the importance of
this region for E1-DNA complex formation. As expected from
our previous results (11), neither of the mutants outside the
FIG. 2. Wild-type BPV-1 origin segment with corresponding mutations in the
E1 binding region. Individual and multiple point mutations spanning the 18-bp
IR element were constructed as described in Materials and Methods. The wild-
type sequence (WT) is shown at the top, with the subsequent mutated positions
shown below. Mutants are designated by their nucleotide numbers and base
changes, except for the double mutants, which are designated DB1 and DB4. The
position of the 18-bp IR element is indicated by the bracket above the wild-type
sequence.
FIG. 3. Representative ratio binding assay. Binding of E1 to the wild-type
and mutant DNA fragments was performed by immunoprecipitation as described
in Materials and Methods. Shown are the bound DNA fragments that were
extracted from the immunoprecipitates, analyzed on a 10% polyacrylamide gel,
and visualized by autoradiography. Binding reactions for lanes WT through 14C
were performed with extracts containing E1 that had been immunoprecipitated
with anti-E1 serum. The lower band in each of these lanes is the 205-bp wild-type
fragment included as a recovery control and competitor, while the upper band in
each of these lanes is the 256-bp wild-type or mutated fragment as indicated.
Binding specificity controls are shown in lanes A-D. Lane A shows the input
DNA consisting of the 256-bp wild-type origin fragment (upper band) and a
151-bp pUC fragment lacking BPV-1 origin sequences (lower band). Immuno-
precipitations were performed with anti-E1 serum (lanes B and D) or preim-
mune serum (lane C) with extracts that contained (lanes C and D) or lacked
(lane B) E1 protein.
FIG. 4. Summary of binding and replication results with individual point
mutations. For both panels, the wild-type origin sequence from nucleotides 7932
to 16 is shown along the x axis. The location of the 18-bp IR element is indicated
by brackets. Letters above the bars on the graphs indicate nucleotide changes at
those positions. Where two mutations were available at a single nucleotide
position, their values are shown by a bar with both shading and black. (A) Shown
is the average amount of E1 binding to each mutant DNA relative to that binding
to the 205-bp wild-type DNA fragment (ratio assay) (averages are based on a
minimum of three experiments; the standard error of the mean was between 0.05
and 0.10 for each sample). (B) Summary of transient DNA replication of origin
point mutations. Individual point mutations were tested for in vivo transient
DNA replication by the ratio assay as described in Materials and Methods. Each
mutant was tested a minimum of three times, and the amount of replicated DNA
was quantitated and compared with that of wild-type pBOR. Shown is the
average replication for each mutant normalized to wild-type pBOR replication
(100%). For graphical purposes, the relative replication levels of the mutations
were grouped as follows: (i) from 10 to 25% of wild-type levels graphed as 25, (ii)
from 26 to 50% of wild-type levels graphed as 50, (iii) from 51 to 75% of
wild-type levels graphed as 75, (iv) and from 76 to 110% of wild-type levels
graphed as 100. There was only one mutant outside this range, 7933C, which
replicated at 120% of wild-type levels, as shown. Note that all individual point
mutants were able to replicate and that none had an efficiency less than 10%.
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18-bp IR region (7933C and 14C) was significantly impaired
for E1 binding. However, binding to mutant 14C was consis-
tently reduced by 20 to 40% compared with that of the wild
type. This was unexpected, since it was previously shown that
nucleotides 13 to 15 could be deleted without affecting E1
binding (26). This slightly reduced binding to the 14C mutant
may indicate that the specific nucleotide composition of the
flanking sequences can make subtle contributions to overall
E1-DNA complex stability.
The 18-bp IR element is an imperfect IR as positions 4
(nucleotide 7943G) and 15 (nucleotide 9T) are not comple-
mentary. Two of the mutations generated in this region, 7943A
and 9C, restored perfect symmetry to the IR. However, the
binding of E1 to these perfect IR elements was slightly reduced
compared with that of the wild-type imperfect IR sequence.
Clearly there was no enhanced binding, indicating that a per-
fect IR sequence did not facilitate E1-DNA interactions. The
only mutation that consistently gave enhanced binding was at
nucleotide 7, where a change from the wild-type A to a T
residue resulted in a 50% increase in binding. The significance
of the enhanced binding with this particular substitution is
unclear.
Examination of the seven positions where two nucleotide
substitutions were available revealed different levels of toler-
ance for change. At position 7942, neither of the nucleotide
changes reduced E1 binding significantly, while at position 8
both changes strongly impaired E1 binding. At each of the
other five positions (nucleotides 7943, 3, 7, 9, and 11), one
mutation had little effect on E1 binding while the other re-
duced binding by 60 to 90%.
Binding of E1 to double mutants suggests interplay between
each half of the 18-bp IR element. In addition to the collection
of single point mutations discussed above, the mutagenesis
procedure also generated origin clones with multiple point
mutations or small deletions. One of the mutations consisted
of a single base deletion at nucleotide 7945 in the 59 half of the
IR. Binding of E1 to this mutant DNA was less than 20% of
that of the wild type (data not shown), which is in agreement
with a similar single base deletion mutation described by Spal-
holz et al. (41). Most of the more complex mutations were
extremely impaired for E1 binding (data not shown), and in-
terpretation of their phenotypes was difficult since it was not
clear how each of their individual mutations contributed to the
binding defect. There were, however, two double mutants,
DB1 and DB4, for which each of their mutations was also
available as a single mutation (Fig. 5). DB1 contained two
mutations in the 59 half of the IR, while DB4 contained one
mutation in each half of the IR. For the mutations comprising
DB1, 3C alone caused no impairment of E1 binding while
7940C reduced binding by 60%. The binding phenotype of
DB1 reflected the defect in 7940C; therefore, having two mu-
tations in one half of the IR was no worse than having the more
severe single mutation. In contrast, neither of the individual
mutations comprising DB4 caused any reduction of E1 bind-
ing, but DB4 itself was significantly impaired. This suggests
that having mutations in both halves of the IR is deleterious
even if neither individual mutation affects E1 binding.
In vivo replication of E1 binding site mutants. To com-
pare E1 binding with origin replication function, the wild-type
and mutant BPV-1 DNA fragments were subcloned from
M13mp18 into a pUC18 background and were assayed for
transient DNA replication in vivo. Evaluation in the pUC18
background rather than in the context of the viral genome was
chosen because of the transcriptional complexity of the origin
region; the functional origin overlaps the P7940 promoter and is
just upstream of the P89 promoter (1, 2, 21). In the context of
the viral genome, it would be difficult to distinguish between
replication and transcriptional effects, since the mutations
might be affecting viral gene expression, which could indirectly
affect replication competence.
For the direct replication assay, each construct was electro-
porated into either C127 or CHO cells. The replication signal
was stronger in CHO cells, but the relative replication of each
mutant origin compared with that of the wild type was un-
changed (data not shown). Along with the origin constructs, E1
and E2 expression vectors were coelectroporated to supply the
critical viral proteins. For the ratio assay, a fourth construct,
pBOR622, was included in each electroporation at a ratio of 1
to 5 with the wild-type or origin mutation construct. pBOR622
consists of the wild-type BPV-1 105-bp origin fragment in a
pUC18 background that is 622 bp larger than wild-type
pUC18. The pBOR622 construct served as an internal stan-
dard for sample handling and recovery during the replication
assay.
Figure 6 shows a representative replication assay for pBOR
and five of the mutants. As expected, replication in this system
was dependent upon both the viral E1 and E2 proteins and a
BPV-1 origin. The parental pUC18 vector did not replicate
under any condition (data not shown), while pBOR replicated
only in the presence of both E1 and E2 (compare lanes 1 and
2). In addition, the amount of DpnI-resistant pBOR product
increased with time and was sensitive to MboI digestion (not
shown). All of these features are consistent with authentic
BPV-1 origin-dependent replication. In the presence of
pBOR622, both pBOR (lower band) and pBOR622 (upper
band) replicated at a ratio of 5 to 1, which was consistent with
their input ratios. Each of the mutant clones shown, as well as
every other single point mutation tested (Fig. 4B), was able to
replicate to some degree. However, after normalization of
recovery with the pBOR622 band, the mutant origin clones
FIG. 5. Binding of E1 to and replication of the double mutants. Shown are
BPV-1 origin region sequences for the wild-type clone (WT), two double muta-
tions (DB1 and DB4), and four point mutations (7940C, 3C, 7942C, and 12C).
The mutated nucleotides are shown in the boldface rectangles. Above the wild-
type sequence, the location of the HpaI site is indicated with a bracket. The 59
(A) and 39 (B) halves of the 18-bp IR are indicated below the wild-type sequence.
Binding of E1 to the mutant fragments was assessed with the ratio assay and
quantitated as described in Materials and Methods. The numbers in the binding
column give the relative binding to the mutant fragment compared with the
wild-type fragment and are the averages of at least three experiments. The values
in the replication column are the replication levels relative to those of the
wild-type origin (1111, 76 to 110%; 111, 51 to 75%; 11, 26 to 50%; 1, 10
to 25%). Replication was assayed and quantitated as described in Materials and
Methods.
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replicated with efficiencies varying from essentially wild-type
levels (7942C) to less than 25% of wild-type levels (8C).
Figure 4B shows a quantitative summary of the relative
replication levels of the 27 single point mutations examined. Of
the 25 single mutations within the 18-bp IR region, 15 gave
levels of replication greater than or equal to 50% of that of the
wild-type origin, indicating that there was little or no defect in
their replication functions. The remaining 10 mutations re-
sulted in more significant replication defects, though all 10
mutants were capable of detectable replication. Neither of the
mutations which restored perfect symmetry to the IR element
(7943A and 9C) resulted in enhanced origin activity, as both
replicated at or just below wild-type levels. Both of the point
mutations outside the 18-bp IR sequence (7933C and 14C)
replicated at or near wild-type levels, which was consistent with
their minimal effects on E1 binding and also indicated that
these mutations did not affect the functions of other critical
origin elements.
In addition to the single point mutations, the two double
mutants, DB1 and DB4, were also assayed for replication (Fig.
5). Both of the point mutations comprising DB1, 7940C and
3C, were located in the 59 half of the IR element. The repli-
cation of 3C was essentially wild type, and that of 7940C was
somewhat reduced. DB1 replication was similar to that of the
mutant with the more severe single mutation, 7940C. The
results for DB1 were in contrast to those for DB4, whose
component single mutations were located in separate halves of
the IR. In this case, both single mutants replicated at wild-type
levels, while DB4 was severely impaired and replicated at only
10 to 25% of wild-type levels. Together, the results with DB1
and DB4 suggest that simultaneous damage to both halves of
the IR is more debilitating for replication than are two muta-
tions within one half site. A similar conclusion was reached for
the effects of these mutations on E1 binding, and it is likely that
the replication of these two double mutants directly reflects
their relative abilities to be bound by E1.
E1 binding and replication capacity of the single point mu-
tants are consistent with functional symmetry of the 18-bp
region. To facilitate analysis of the numerous point mutations,
the properties of identical mutations at equivalent positions in
each half of the 18-bp region were compared (on the basis of
data in Fig. 4). There were five positions where the same
mutation was available in each half site: 7941A/11T, 7942G/
10C, 7943T/9A, 7944C/8G, and 7945A/7T. With one exception
(mutation 7945A versus 7T), equivalent mutations in each half
of the IR element exhibited very similar degrees of E1 binding.
While the significance of the one exception is unclear, the
overall symmetrical trend suggests that the two half sites are
functionally equivalent with respect to E1 binding. Likewise, at
four of the five positions where identical mutations were avail-
able in both half sites, levels of replication were very similar,
implying an overall functional symmetry of the half sites. Only
at one pair of mutations, 7942G/10C, was there a disparity in
replication, with 7942G replicating poorly while 10C replicated
at near wild-type levels. The significance of the disparity be-
tween 7942G and 10C is unknown but may reflect the intrinsic
asymmetry in the organization of the origin region. The E1
binding site is flanked by an AT-rich region on the 59 side and
an E2 binding site on the 39 side. The difference in replication
for 7942G and 10C may reflect how E1 bound to the 59 and 39
halves of the IR element interacts with the adjacent elements.
Given the apparent functional equivalency of the 59 and 39
halves of the IR for binding and replication, the mutational
data for each half site were combined for further analysis. This
allowed the evaluation of the effect on binding (data not
shown) or replication (Fig. 7) of two or more nucleotide
changes at each position in the half site. The effect of a muta-
tion on replication depended on both the position of the mu-
tation and the specific nucleotide change. Three of nine posi-
tions in the half site replicated well with any of three
nucleotides (positions 7940, 7945, and 3), while only one po-
sition failed to replicate well with either available mutation
(position 7944). The other five positions retained significant
replication with certain nucleotide changes but not with others.
On the basis of these levels of replication with different avail-
able mutations, a consensus half site sequence of nucleotides
critical for replication was derived. A similar analysis of the
effect of mutations on E1 binding was performed (not shown),
and this analysis defined the consensus half site sequence of
nucleotides (Fig. 7) required for efficient E1-DNA interaction.
The consensus for replication function was very similar to the
FIG. 6. Representative transient DNA replication of pBOR and origin mu-
tations. Transient replication assays were performed as described in Materials
and Methods with C127 cells, and a representative Southern blot is shown. The
E1 and E2 expression vectors were included (1) or excluded (2) as indicated.
Plasmid pBOR622 was coelectroporated with certain samples as indicated by the
bracket above lanes 3 to 8. DNA was harvested at either 3 days (lanes 1 and 2)
or 5 days (lanes 3 to 8) postelectroporation and was digested with DpnI and
HindIII. The position of the linear, DpnI-insensitive (replicated) DNA is indi-
cated by the bracket and R to the right. In each lane, the upper replicated band
corresponds to pBOR622 and the lower band corresponds to the pBOR clone.
Designations above lanes 3 to 7 indicate the BPV-1 nucleotide position and the
nucleotide change of the mutations being tested. Note that 42C corresponds to
BPV-1 nucleotide 7942.
FIG. 7. Summary of replication data and a derived consensus sequence for
the 18-bp IR half site. Shown in bold capitals is the wild-type BPV-1 sequence
from nucleotides 7940 to 3, which constitutes the 59 half of the 18-bp IR element.
Individual nucleotide changes that replicated at $50% of wild-type levels are
shown above the wild-type sequence, while mutations that reduced replication to
,50% of wild-type levels are shown below. Mutations from both half sites were
combined into a single half site for evaluative purposes as discussed in the text.
Mutations derived from the 59 and 39 halves of the 18-bp IR are given in
uppercase and italicized lowercase letters, respectively. Above the mutations is
the consensus sequence for nucleotides critical for replication function. This
consensus was derived from the available mutations that replicated at $50% of
wild-type levels. The dash in the consensus sequence indicates that at least three
different nucleotides could occupy that position and maintain near wild-type
replication. Above the replication consensus sequence is the binding consensus
sequence derived in a similar fashion from the binding data in Fig. 4A.
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consensus derived for E1 binding, consistent with an essential
requirement for E1 binding in order to initiate replication.
DISCUSSION
It has been shown previously that sequences within an 18-bp
IR element at the BPV-1 origin of replication are required for
binding of E1 protein (11). In the present study, a large col-
lection of point mutations in the 18-bp IR element was created
to evaluate the contribution of individual nucleotides to E1-
DNA complex formation. Direct binding studies revealed that
most of the mutations reduced E1 binding, confirming the
importance of this region for specifying E1-DNA interactions.
The mutational analysis also revealed a hierarchy of tolerance
to nucleotide changes. On the basis of the binding consensus
sequence, nucleotide positions 5 and 7 (from left to right in
Fig. 7) were intolerant of change; binding was severely reduced
with any nucleotide substitution, suggesting that E1 made crit-
ical contacts with these nucleotide positions. Position 3 was
tolerant of any mutation and, therefore, appeared unimportant
for specific E1-DNA interactions. The remaining positions
were intermediate in that they could tolerate either of two
nucleotides. However, these positions usually required the
maintenance of a purine or pyrimidine or of an AT pair.
All of the single point mutations discussed above were only
partially defective for E1 binding. Given the symmetry of the
E1 binding region, one interpretation of this result is that the
18-bp region represents two adjacent half sites for E1 binding.
However, since neither half site alone is sufficient for E1 bind-
ing (11), cooperative E1-E1 interactions between molecules
bound to each half site must be required for stable protein-
DNA complex formation. In this situation, if there is a muta-
tion in only one half of the IR, E1 interaction with the wild-
type half may facilitate and stabilize binding of E1 to the
mutated half and allow partial binding such as that observed
with the single mutations and DB1. Also, this model predicts
that simultaneous mutations in both half sites would be more
detrimental to binding than would either single mutation
alone, which was observed for DB4.
A cooperative binding model is also supported by direct
E1-DNA binding curves (26, 39) and studies of E1 assembly at
the origin (27). It has been estimated recently that the minimal
E1-DNA complex has two molecules of E1 and that a larger
oligomeric complex forms that is necessary for DNA replica-
tion (27). While it has not been determined in our binding
system which type of complex is forming, our data are consis-
tent with each half site of the IR element serving as a binding
site for E1 molecules. Whether E1 binds DNA as a monomer
and then forms protein-protein contacts while on the DNA has
not been determined. However, E1 can form oligomeric struc-
tures in solution (12), suggesting that the initial interaction
may be between 18-bp IR sequences and dimeric E1. The
subsequent recruitment of additional E1 molecules would gen-
erate the larger complex observed by Lusky et al. (27) and
explain the extended protection seen in footprinting assays (10,
11, 47, 51).
In conjunction with the E1 binding studies, origin mutations
were assayed for replication in the context of a 105-bp origin
fragment cloned into pUC18, with E1 and E2 proteins supplied
in trans from heterologous expression vectors. Analysis of the
mutations outside of the context of the viral genome avoided
any complication caused by pleiotropic effects of the mutations
on other viral functions, e.g., transcription, which could indi-
rectly influence replication levels. Therefore, the results ob-
tained in this study are a direct reflection of origin replication
function. On the basis of the half site consensus presented in
Fig. 7, only six of the nine positions are critical for replication.
Positions 1, 6, and 9 all tolerate at least three different nucle-
otides without significant impairment of replication. The other
six positions are less tolerant and must represent nucleotides
required for origin.
For the majority of point mutations (15 of 25), replication
levels similar to those of the wild-type origin were obtained
even though in vitro E1 binding was significantly impaired for
6 of the 15 mutant DNAs (7940C, 7945A, 2A, 3A, 6T, and 7G).
However, it is difficult to correlate in vitro E1 binding capacity
with the true affinity of E1 for these six mutant DNAs in vivo.
In vivo, each of these mutant DNAs may be capable of ade-
quate interaction with E1 for replication. Additionally, it has
previously been shown that full-length E2 protein enhances
binding of E1 to wild-type and mutant origins (26, 27, 39, 40).
Consequently, it is possible that the presence of E2 in the
replication assay overcame an inherently poor binding of E1 to
these six mutant origins and allowed normal amounts of rep-
lication complexes to form in vivo. In either case, this suggests
that none of these six nucleotide changes (or the other nine in
this group) affected the ability of E1 to initiate the replication
process at the origin once binding had occurred.
The remaining 10 point mutations all exhibited replication
levels less than 50% of that of the wild-type origin. While 8 of
these 10 mutant DNAs were bound poorly by E1 in vitro, 2
(7942G and 5C) showed moderately good binding. Again, it is
possible that in vitro binding of E1 to these mutant DNAs does
not accurately reflect the in vivo interaction. However, this
implies that the interaction of E1 with all 10 of these DNAs in
vivo was so defective that even the presence of E2 protein was
insufficient to generate normal levels of replication complexes.
A second possibility is that E1 binding alone is not sufficient for
DNA replication as has been previously proposed on the basis
of other origin mutations (41). In this case the failure to rep-
licate at wild-type levels would be attributed to a defect in
some postbinding replicative step rather than to a lack of
adequate E1 binding. For example, E1-origin complexes may
assemble normally on these mutant DNAs but distortion of
origin structure leading to strand separation may be reduced.
Further evaluation of the interaction of E1 and E1-E2 com-
plexes with these mutations should help clarify the basis of the
replication defects.
In summary, this study has identified functionally critical
nucleotides in the origin 18-bp IR element. The general con-
cordance between mutational effects on E1 binding and repli-
cation is consistent with E1 binding to this region being nec-
essary for the initiation of BPV-1 replication. This is in contrast
to recent observations with some human papillomaviruses that
indicate little or no absolute requirement for an E1 binding site
(22, 35, 43). Clearly this implies that there may be fundamental
differences in how various papillomavirus origins are organized
and utilized. More detailed definition of critical elements and
their functional interactions is required to understand the
spectrum of papillomavirus origins.
ACKNOWLEDGMENTS
We thank Gennie Schuller for assistance with production of the
origin mutations.
This work was supported by grants from the Texas Advanced Re-
search Program and by PHS grant CA56699 from the National Insti-
tutes of Health.
REFERENCES
1. Ahola, H., A. Stenlund, J. Moreno-Lo´pez, and U. Pettersson. 1987. Promot-
ers and processing sites within the transforming region of bovine papilloma-
virus type 1. J. Virol. 61:2240–2244.
2. Baker, C. C., and P. M. Howley. 1987. Differential promoter utilization by
the bovine papillomavirus in transformed cells and productively infected
VOL. 69, 1995 CRITICAL SEQUENCES FOR E1 BINDING AND DNA REPLICATION 6531
 o
n
 Septem
ber 12, 2018 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
wart tissues. EMBO J. 6:1027–1035.
3. Berg, L., M. Lusky, A. Stenlund, and M. R. Botchan. 1986. Repression of
bovine papilloma virus replication is mediated by a virally encoded trans-
acting factor. Cell 46:753–762.
4. Berg, L. J., K. Singh, and M. Botchan. 1986. Complementation of a bovine
papilloma virus low-copy-number mutant: evidence for a temporal require-
ment of the complementing gene. Mol. Cell. Biol. 6:859–869.
5. Blitz, I. L., and L. A. Laimins. 1991. The 68-kilodalton E1 protein of bovine
papillomavirus is a DNA binding phosphoprotein which associates with the
E2 transcriptional activator in vitro. J. Virol. 65:649–656.
6. Bonne-Andrea, C., S. Santucci, and P. Clertant. 1995. Bovine papillomavirus
E1 protein can, by itself, efficiently drive multiple rounds of DNA synthesis
in vitro. J. Virol. 69:3201–3205.
7. Chesters, P. M., and D. J. McCance. 1985. Human papillomavirus type 16
recombinant DNA is maintained as an autonomously replicating episome in
monkey kidney cells. J. Gen. Virol. 66:615–620.
8. Chiang, C. M., M. Ustav, A. Stenlund, T. F. Ho, T. R. Broker, and L. T.
Chow. 1992. Viral E1 and E2 proteins support replication of homologous
and heterologous papillomaviral origins. Proc. Natl. Acad. Sci. USA 89:
5799–5803.
9. DiMaio, D., R. Treisman, and T. Maniatis. 1982. Bovine papilloma virus
vector that propagates as a plasmid in both mouse and bacterial cells. Proc.
Natl. Acad. Sci. USA 79:4030–4034.
10. Gillette, T. G., M. Lusky, and J. A. Borowiec. 1994. Induction of structural
changes in the bovine papillomavirus type 1 origin of replication by the viral
E1 and E2 proteins. Proc. Natl. Acad. Sci. USA 91:8846–8850.
11. Holt, S. E., G. Schuller, and V. G. Wilson. 1994. DNA binding specificity of
the bovine papillomavirus E1 protein is determined by sequences contained
within an 18-base-pair inverted repeat element at the origin of replication. J.
Virol. 68:1094–1102.
12. Holt, S. E., and V. G. Wilson. 1994. Unpublished observations.
13. Koetsier, P. A., J. Schorr, and W. Doerfler. 1993. A rapid optimized protocol
for downward alkaline Southern blotting of DNA. BioTechniques 15:260–
262.
14. Kuo, S.-R., J.-S. Liu, T. R. Broker, and L. T. Chow. 1994. Cell-free replica-
tion of the human papillomavirus DNA with homologous viral E1 and E2
proteins and human cell extracts. J. Biol. Chem. 269:24058–24065.
15. Lancaster, W. D. 1981. Apparent lack of integration of bovine papilloma
virus DNA in virus-induced equine and bovine tumor cells and virus-trans-
formed mouse cells. Virology 108:251–255.
16. Law, M. F., D. R. Lowy, I. Dvoretzky, and P. M. Howley. 1981. Mouse cells
transformed by bovine papillomavirus contain only extrachromosomal viral
DNA sequences. Proc. Natl. Acad. Sci. USA 78:2727–2731.
17. Leng, X., and V. G. Wilson. 1994. The genetically defined nuclear localiza-
tion signal sequence of bovine papillomavirus E1 protein is necessary and
sufficient for the nuclear localization of E1/b-galactosidase fusion proteins. J.
Gen. Virol. 75:2463–2467.
18. Lentz, M. R., D. Pak, I. Mohr, and M. R. Botchan. 1993. The E1 replication
protein of bovine papillomavirus type 1 contains an extended nuclear local-
ization signal that includes a p34cdc2 phosphorylation site. J. Virol. 67:1414–
1423.
19. Li, R., and M. R. Botchan. 1993. The acidic transcriptional activation do-
mains of VP16 and p53 bind the cellular replication protein A and stimulate
in vitro BPV-1 DNA replication. Cell 73:1207–1221.
20. Li, R., and M. R. Botchan. 1994. Acidic transcription factors alleviate nu-
cleosome-mediated repression of DNA replication of bovine papillomavirus
type 1. Proc. Natl. Acad. Sci. USA 91:7051–7055.
21. Linz, U., and C. C. Baker. 1988. Promoters of bovine papillomavirus type 1:
in vitro activity and utilization. J. Virol. 62:2537–2543.
22. Lu, J. Z. J., Y.-N. Sun, R. C. Rose, W. Bonnez, and D. J. McCance. 1993. Two
E2 binding sites (E2BS) alone or one E2BS plus an A/T-rich region are
minimal requirements for the replication of the human papillomavirus type
11 origin. J. Virol. 67:7131–7139.
23. Lusky, M., and M. R. Botchan. 1985. Genetic analysis of bovine papilloma-
virus type 1 trans-acting replication factors. J. Virol. 53:955–965.
24. Lusky, M., and M. R. Botchan. 1986. A bovine papillomavirus type 1-en-
coded modulator function is dispensable for transient viral replication but is
required for establishment of the stable plasmid state. J. Virol. 60:729–742.
25. Lusky, M., and E. Fontane. 1991. Formation of the complex of bovine
papillomavirus E1 and E2 proteins is modulated by E2 phosphorylation and
depends upon sequences within the carboxyl terminus of E1. Proc. Natl.
Acad. Sci. USA 88:6363–6367.
26. Lusky, M., J. Hurwitz, and Y. S. Seo. 1993. Cooperative assembly of the
bovine papilloma virus E1 and E2 proteins on the replication origin requires
an intact E2 binding site. J. Biol. Chem. 268:15795–15803.
27. Lusky, M., J. Hurwitz, and Y.-S. Seo. 1994. The bovine papillomavirus E2
protein modulates the assembly of but is not stably maintained in a replica-
tion-competent multimeric E1-replication origin complex. Proc. Natl. Acad.
Sci. USA 91:8895–8899.
28. MacPherson, P., L. Thorner, L. M. Parker, and M. Botchan. 1994. The
bovine papilloma virus E1 protein has ATPase activity essential to viral DNA
replication and efficient transformation in cells. Virology 204:403–408.
29. Mohr, I. J., R. Clark, S. Sun, E. J. Androphy, P. MacPherson, and M. R.
Botchan. 1990. Targeting the E1 replication protein to the papillomavirus
origin of replication by complex formation with the E2 transactivator. Sci-
ence 250:1694–1699.
30. Mu¨ller, F., Y.-S. Seo, and J. Hurwitz. 1994. Replication of bovine papillo-
mavirus type 1 origin-containing DNA in crude extracts and with purified
proteins. J. Biol. Chem. 269:17086–17094.
31. Nallaseth, F. S., and M. L. DePamphilis. 1994. Papillomavirus contains
cis-acting sequences that can suppress but not regulate origins of DNA
replication. J. Virol. 68:3051–3064.
32. Park, P., W. Copeland, L. Yang, T. Wang, M. R. Botchan, and I. J. Mohr.
1994. The cellular DNA polymerase a-primase is required for papillomavirus
DNA replication and associates with the viral E1 helicase. Proc. Natl. Acad.
Sci. USA 91:8700–8704.
33. Phalen, D. N., V. G. Wilson, and D. L. Graham. 1991. Polymerase chain
reaction assay for avian polyomavirus. J. Clin. Microbiol. 29:1030–1037.
34. Ravnan, J.-B., D. M. Gilbert, K. G. Ten Hagen, and S. N. Cohen. 1992.
Random-choice replication of extrachromosomal bovine papillomavirus
(BPV) molecules in heterogeneous, clonally derived BPV-infected cell lines.
J. Virol. 66:6946–6952.
35. Russell, J., and M. R. Botchan. 1995. cis-acting components of human
papillomavirus (HPV) DNA replication: linker substitution analysis of the
HPV type 11 origin. J. Virol. 69:651–660.
36. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a
laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold
Spring Harbor, N.Y.
37. Santucci, S., E. J. Androphy, C. Bonne-Andrea, and P. Clertant. 1990.
Proteins encoded by the bovine papillomavirus E1 open reading frame:
expression in heterologous systems and in virally transformed cells. J. Virol.
64:6027–6039.
38. Sarver, N., J. C. Byrne, and P. M. Howley. 1982. Transformation and repli-
cation in mouse cells of a bovine papillomavirus-pML2 plasmid vector that
can be rescued in bacteria. Proc. Natl. Acad. Sci. USA 79:7147–7151.
39. Seo, Y.-S., F. Mu¨ller, M. Lusky, E. Gibbs, H.-Y. Kim, B. Phillips, and J.
Hurwitz. 1993. Bovine papilloma virus (BPV)-encoded E2 protein enhances
binding of E1 protein to the BPV replication origin. Proc. Natl. Acad. Sci.
USA 90:2865–2869.
40. Seo, Y. S., F. Mu¨ller, M. Lusky, and J. Hurwitz. 1993. Bovine papilloma virus
(BPV)-encoded E1 protein contains multiple activities required for BPV
DNA replication. Proc. Natl. Acad. Sci. USA 90:702–706.
41. Spalholz, B. A., A. A. McBride, T. Sarafi, and J. Quintero. 1993. Binding of
bovine papillomavirus E1 to the origin is not sufficient for DNA replication.
Virology 193:201–212.
42. Sun, S., L. Thorner, M. Lentz, P. MacPherson, and M. Botchan. 1990.
Identification of a 68-kilodalton nuclear ATP-binding phosphoprotein en-
coded by bovine papillomavirus type 1. J. Virol. 64:5093–5105.
43. Sverdrup, F., and S. A. Khan. 1995. Two E2 binding sites alone are sufficient
to function as the minimal origin of replication of human papillomavirus type
18 DNA. J. Virol. 69:1319–1323.
44. Thorner, L. K., D. A. Lim, and M. R. Botchan. 1993. DNA-binding domain
of bovine papillomavirus type 1 E1 helicase: structural and functional as-
pects. J. Virol. 67:6000–6014.
45. Ustav, E., M. Ustav, P. Szymanski, and A. Stenlund. 1993. The bovine
papillomavirus origin of replication requires a binding site for the E2 tran-
scriptional activator. Proc. Natl. Acad. Sci. USA 90:898–902.
46. Ustav, M., and A. Stenlund. 1991. Transient replication of BPV-1 requires
two viral polypeptides encoded by the E1 and E2 open reading frames.
EMBO J. 10:449–457.
47. Ustav, M., E. Ustav, P. Szymanski, and A. Stenlund. 1991. Identification of
the origin of replication of bovine papillomavirus and characterization of the
viral origin recognition factor E1. EMBO J. 10:4321–4329.
48. Wilson, V. G., and J. Ludes-Meyers. 1991. A bovine papillomavirus E1-
related protein binds specifically to bovine papillomavirus DNA. J. Virol.
65:5314–5322.
49. Wilson, V. G., and J. Ludes-Meyers. 1992. Partite expression of the bovine
papillomavirus E1 open reading frame in Escherichia coli. Biochim. Biophys.
Acta 1129:215–218.
50. Wilson, V. G., and G. Schuller. 1994. PCR-SSCP screening of M13 plaques.
Focus 16:59–62.
51. Yang, L., R. Li, I. J. Mohr, R. Clark, and M. R. Botchan. 1991. Activation of
BPV-1 replication in vitro by the transcription factor E2. Nature (London)
353:628–632.
52. Yang, L., I. Mohr, E. Fouts, D. A. Lim, M. Nohaile, and M. Botchan. 1993.
The E1 protein of bovine papilloma virus 1 is an ATP-dependent DNA
helicase. Proc. Natl. Acad. Sci. USA 90:5086–5090.
53. Yang, L., I. Mohr, R. Li, T. Nottoli, S. Sun, and M. Botchan. 1991. Tran-
scription factor E2 regulates BPV-1 DNA replication in vitro by direct
protein-protein interaction. Cold Spring Harbor Symp. Quant. Biol. 56:335–
346.
54. zur Hausen, H. 1991. Human papillomaviruses in the pathogenesis of ano-
genital cancer. Virology 184:9–13.
6532 HOLT AND WILSON J. VIROL.
 o
n
 Septem
ber 12, 2018 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
